Isoferulic acid, a new anti-glycation agent, inhibits fructoseand glucose-mediated protein glycation in vitro

Molecules

Volumn 18, Issue 6, 2013, Pages 6439-6454

  Meeprom, Aramsri ^a   Sompong, Weerachat ^a   Chan, Catherine B ^b   Adisakwattana, Sirichai ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Advanced glycation end products; Fructosamine; Isoferulic acid; N (carboxymethyl)lysine; Protein glycation; Protein oxidation

Indexed keywords

ADVANCED GLYCATION END PRODUCT; BOVINE SERUM ALBUMIN; CINNAMIC ACID DERIVATIVE; FRUCTOSE; GLUCOSE; ISOFERULIC ACID; PROTEIN;

CHEMISTRY; DRUG EFFECTS; GLYCOSYLATION; METABOLISM; ARTICLE; DRUG EFFECT;

CINNAMATES; FRUCTOSE; GLUCOSE; GLYCOSYLATION; GLYCOSYLATION END PRODUCTS, ADVANCED; PROTEINS; SERUM ALBUMIN, BOVINE;

EID: 84879652646     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules18066439     Document Type: Article

References (49)

1. Ahmed, N. Advanced glycation endproducts - Role in pathology of diabetic complications. Diabetes Res. Clin. Pract. 2005, 67, 3-21.
2. Negre-Salvayre, A.; Salvayre, R.; Augé, N.; Pamplona, R.; Portero-Otín, M. Hyperglycemia and glycation in diabetic complications. Antioxid. Redox. Signal. 2009, 11, 3071-3109.
3. Vinson, J.A.; Howard III, T.B. Inhibition of protein glycation and advanced glycation end products by ascorbic acid and other vitamins and nutrients. J. Nutr. Biochem. 1996, 7, 659-663.
4. Ardestani, A.; Yazdanparast, R. Inhibitory effects of ethyl acetate extract of teucrium polium on in vitro protein glycoxidation. Food Chem. Toxicol. 2007, 45, 2402-2411.
5. Bär, K.J.; Franke, S.; Wenda, B.; Müller, S.; Kientsch-Engel, R.; Stein, G.; Sauer, H. Pentosidine and n(epsilon)-(carboxymethyl)-lysine in alzheimer's disease and vascular dementia. Neurobiol. Aging. 2003, 24, 333-338.
6. Dworacka, M.; Winiarska, H.; Szymańska, M.; Szczawińska, K.; Wierusz-Wysocka, B. Serum n-epsilon-(carboxymethyl)lysine is elevated in nondiabetic coronary heart disease patients. J. Basic Clin. Physiol. Pharmacol. 2002, 13, 201-213.
7. Ulrich, P.; Cerami, A. Protein glycation, diabetes, and aging. Recent Prog. Horm. Res. 2001, 56, 1-21.
8. Khazaei, M.R.; Bakhti, M.; Habibi-Rezaei, M. Nicotine reduces the cytotoxic effect of glycated proteins on microglial cells. Neurochem. Res. 2010, 35, 548-558.
9. Kousar, S.; Sheikh, M.A.; Asghar, M.; Sarwar, M. Effect of aminoguanidine on advanced glycation end products (ages) using normal and diabetic plasma. J. Chem. Soc. Pak. 2009, 31, 109-114.
10. Yamagishi, S.; Nakamura, K.; Matsui, T.; Ueda, S.; Fukami, K.; Okuda, S. Agents that block advanced glycation end product (age)-rage (receptor for ages)-oxidative stress system: A novel therapeutic strategy for diabetic vascular complications. Expert Opin. Investig. Drugs 2008, 17, 983-996.
11. Giardino, I.; Fard, A.K.; Hatchell, D.L.; Brownlee, M. Aminoguanidine inhibits reactive oxygen species formation, Lipid peroxidation, And oxidant-induced apoptosis. Diabetes 1998, 47, 1114-1120.
12. Ihm, S.-H.; Yoo, H.J.; Park, S.W.; Ihm, J. Effect of aminoguanidine on lipid peroxidation in streptozotocin-induced diabetic rats. Metabolism 1999, 48, 1141-1145.
13. Bolton, W.K.; Cattran, D.C.; Williams, M.E.; Adler, S.G.; Appel, G.B.; Cartwright, K.; Foiles, P.G.; Freedman, B.I.; Raskin, P.; Ratner, R.E.; et al. Randomized trial of an inhibitor of formation of advanced glycation end products in diabetic nephropathy. Am. J. Nephrol. 2004, 24, 32-40.
14. Tupe, R.; Agte, V. Interaction of zinc, ascorbic acid, and folic acid in glycation with albumin as protein model. Biol. Trace Elem. Res. 2010, 138, 346-357.
15. Ardestani, A.; Yazdanparast, R. Cyperus rotundus suppresses age formation and protein oxidation in a model of fructose-mediated protein glycoxidation. Int. J. Biol. Macromol. 2007, 41, 572-578.
16. Iwanaga, A.; Kusano, G.; Warashina, T.; Miyase, T. Hyaluronidase inhibitors from "cimicifugae rhizoma" (a mixture of the rhizomes of cimicifuga dahurica and c. Heracleifolia). J. Nat. Prod. 2010, 73, 573-578.
17. Sakai, S.; Kawamata, H.; Kogure, T.; Mantani, N.; Terasawa, K.; Umatake, M.; Ochiai, H. Inhibitory effect of ferulic acid and isoferulic acid on the production of macrophage inflammatory protein-2 in response to respiratory syncytial virus infection in raw264.7 cells. Mediators Inflamm. 1999, 8, 173-175.
18. Hirabayashi, T.; Ochiai, H.; Sakai, S.; Nakajima, K.; Terasawa, K. Inhibitory effect of ferulic acid and isoferulic acid on murine interleukin-8 production in response to influenza virus infections in vitro and in vivo. Planta Med. 1995, 61, 221-226.
19. Schmid, D.; Woehs, F.; Svoboda, M.; Thalhammer, T.; Chiba, P.; Moeslinger, T. Aqueous extracts of cimicifuga racemosa and phenolcarboxylic constituents inhibit production of proinflammatory cytokines in lps-stimulated human whole blood. Can. J. Physiol. Pharmacol. 2009, 87, 963-972.
20. Sakai, S.; Ochiai, H.; Mantani, N.; Kogure, T.; Shibahara, N.; Terasawa, K. Administration of isoferulic acid improved the survival rate of lethal influenza virus pneumonia in mice. Mediators Inflamm. 2001, 10, 93-96.
21. Hirata, A.; Murakami, Y.; Atsumi, T.; Shoji, M.; Ogiwara, T.; Shibuya, K.; Ito, S.; Yokoe, I.; Fujisawa, S. Ferulic acid dimer inhibits lipopolysaccharide-stimulated cyclooxygenase-2 expression in macrophages. In Vivo 2005, 19, 849-853.
22. Wang, X.; Li, X.; Chen, D. Evaluation of antioxidant activity of isoferulic acid in vitro. Nat. Prod. Commun. 2011, 6, 1285-1288.
23. Liu, I.M.; Hsu, F.L.; Chen, C.F.; Cheng, J.T. Antihyperglycemic action of isoferulic acid in streptozotocin-induced diabetic rats. Br. J. Pharmacol. 2000, 129, 631-636.
24. Liu, I.M.; Chen, W.C.; Cheng, J.T. Mediation of beta-endorphin by isoferulic acid to lower plasma glucose in streptozotocin-induced diabetic rats. J. Pharmacol. Exp. Ther. 2003, 307, 1196-1204.
25. Adisakwattana, S.; Sompong, W.; Meeprom, A.; Ngamukote, S.; Yibchok-anun, S. Cinnamic acid and its derivatives inhibit fructose-mediated protein glycation. Int. J. Mol. Sci. 2012, 13, 1778-1789.
26. Booth, A.A.; Khalifah, R.G.; Todd, P.; Hudson, B.G. In vitro kinetic studies of formation of antigenic advanced glycation end products (AGEs). Novel inhibition of post-amadori glycation pathways. J. Biol. Chem. 1997, 272, 5430-5437.
27. Goh, S.Y.; Cooper, M.E. Clinical review: The role of advanced glycation end products in progression and complications of diabetes. J. Clin. Endocrinol. MeTable 2008, 93, 1143-1152.
28. Takagi, Y.; Kashiwagi, A.; Tanaka, Y.; Asahina, T.; Kikkawa, R.; Shigeta, Y. Significance of fructose-induced protein oxidation and formation of advanced glycation end product. J. Diabetes Complications 1995, 9, 87-91.
29. Suárez, G.; Rajaram, R.; Oronsky, A.L.; Gawinowicz, M.A. Nonenzymatic glycation of bovine serum albumin by fructose (fructation). Comparison with the maillard reaction initiated by glucose. J. Biol. Chem. 1989, 264, 3674-3679.
30. Shield, J.P.; Poyser, K.; Hunt, L.; Pennock, C.A. Fructosamine and glycated haemoglobin in the assessment of long term glycaemic control in diabetes. Arch. Dis. Child. 1994, 71, 443-445.
31. Wu, C.H.; Huang, S.M.; Lin, J.A.; Yen, G.C. Inhibition of advanced glycation endproduct formation by foodstuffs. Food Funct. 2011, 2, 224-234.
32. Singh, R.; Barden, A.; Mori, T.; Beilin, L. Advanced glycation end-products: A review. Diabetologia 2001, 44, 129-146.
33. Hunt, J.V.; Wolff, S.P. Oxidative glycation and free radical production: A causal mechanism of diabetic complications. Free Radic. Res. Commun. 1991, 12-13, 115-123.
34. Kalousová, M.; Zima, T.; Tesar, V.; Lachmanová, J. Advanced glycation end products and advanced oxidation protein products in hemodialyzed patients. Blood Purif. 2002, 20, 531-536.
35. Aćimović, J.M.; Stanimirović, B.D.; Mandić, L.M. The role of the thiol group in protein modification with methylglyoxal. J. Serb. Chem. Soc. 2009, 74, 867-883.
36. Dalle-Donne, I.; Rossi, R.; Giustarini, D.; Milzani, A.; Colombo, R., Protein carbonyl groups as biomarkers of oxidative stress. Clin. Chim. Acta 2003, 329, 23-38.
37. Balu, M.; Sangeetha, P.; Murali, G.; Panneerselvam, C. Age-related oxidative protein damages in central nervous system of rats: Modulatory role of grape seed extract. Int. J. Dev. Neurosci. 2005, 23, 501-507.
38. Cai, Y.-Z.; Sun, M.; Xing, J.; Luo, Q.; Corke, H. Structure-radical scavenging activity relationships of phenolic compounds from traditional chinese medicinal plants. Life Sci. 2006, 78, 2872-2888.
39. Peyroux, J.; Sternberg, M. Advanced glycation endproducts (AGEs): Pharmacological inhibition in diabetes. Pathol. Biol. 2006, 54, 405-419.
40. Price, D.L.; Rhett, P.M.; Thorpe, S.R.; Baynes, J.W. Chelating activity of advanced glycation end-product inhibitors. J. Biol. Chem. 2001, 276, 48967-48972.
41. Peng, X.; Ma, J.; Chen, F.; Wang, M., Naturally occurring inhibitors against the formation of advanced glycation end-products. Food Funct. 2011, 2, 289-301.
42. Bouma, B.; Kroon-Batenburg, L.M.; Wu, Y.P.; Brünjes, B.; Posthuma, G.; Kranenburg, O.; de Groot, P.G.; Voest, E.E.; Gebbink, M.F. Glycation induces formation of amyloid cross-beta structure in albumin. J. Biol. Chem. 2003, 278, 41810-41819.
43. Hardy, J.; Selkoe, D.J. The amyloid hypothesis of alzheimer's disease: Progress and problems on the road to therapeutics. Science 2002, 297, 353-356.
44. Marzban, L.; Soukhatcheva, G.; Verchere, C.B. Role of carboxypeptidase e in processing of pro-islet amyloid polypeptide in β-cells. Endocrinology 2005, 146, 1808-1817.
45. Tokuyama, T.; Yagui, K.; Yamaguchi, T.; Huang, C.I.; Kuramoto, N.; Shimada, F.; Miyazaki, J.; Horie, H.; Saito, Y.; Makino, H.; et al. Expression of human islet amyloid polypeptide/amylin impairs insulin secretion in mouse pancreatic beta cells. Metabolism 1997, 46, 1044-1051.
46. Marzban, L.; Verchere, C.B. The role of islet amyloid polypeptide in type 2 diabetes. Can. J. Diabetes 2004, 28, 39-47.
47. Levine, R.L.; Garland, D.; Oliver, C.N.; Amici, A.; Climent, I.; Lenz, A.G.; Ahn, B.W.; Shaltiel, S.; Stadtman, E.R. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol. 1990, 186, 464-478.
48. Ellman, G.L. Tissue sulfhydryl groups. Arch. Biochem. Biophys. 1959, 82, 70-77.
49. Tupe, R.S.; Agte, V.V. Role of zinc along with ascorbic acid and folic acid during long-term in vitro albumin glycation. Br. J. Nutr. 2010, 103, 370-377. Metabolic Diseases